Induction of amelogenin and ameloblastin by insulin and insulin-like growth factors (IGF-I and IGF-II) during embryonic mouse tooth development in vitro
K. Takahashi et al., Induction of amelogenin and ameloblastin by insulin and insulin-like growth factors (IGF-I and IGF-II) during embryonic mouse tooth development in vitro, CONNECT TIS, 39(1-3), 1998, pp. 269-278
Insulin and insulin-like growth factors (IGF-I and IGF-II) are considered p
leiotropic, acting as both mitogen and differentiation factors. Several inv
estigators have demonstrated the expression of insulin, IGFs, their cognate
receptors and IGF binding proteins during tooth morphogenesis, Previous wo
rk done in our laboratory indicated that exogenous insulin and IGFs induce
the accumulation of enamel extracellular matrix on mouse mandibular molars
cultured in a serumless, chemically defined medium. In order to determine t
he level of control of these factors in the induction of enamel biominerali
zation, we designed experiments to quantitate mRNAs for enamel specific-gen
e products. Mandibular first molars (M1) obtained from E15 Swiss Webster mi
ce were placed in organ culture in the presence of insulin (1000 ng/ml), IG
F-I (100 ng/ml) or IGF-II (100 ng/ml) for 6, 12 and 18-days. At termination
date, the RNA was extracted and the concentration of mRNAs for amelogenin,
tuftelin and ameloblastin were determined using a quantitative competitive
reverse transcription-polymerase chain reaction (RT-PCR) technique (PCR mi
mic), Our results showed that after 6-days in culture; treatment with insul
in, IGF-I and IGF-II increased the synthesis of amelogenin and ameloblastin
. In contrast, the expression of tuftelin mRNA was not affected by either f
actor. In conclusion, our studies showed that the increase in enamel matrix
formation by overexpression of IGFs is the result of transcriptional regul
ation of enamel specific proteins like amelogenin and ameloblastin but not
tuftelin, These studies also suggest that the regulatory mechanisms control
ling tuftelin gene expression are different than the mechanisms regulating
ameloblastin and amelogenin transcription.